Though lower levels of sphingomyelins in the blood are beneficial, reduced sphingomyelin levels in the brain are detrimental, with AD brains exhibiting reduced sphingomyelin levels [90, 91] with reductions more pronounced in APOE E4 as compared to other isoforms [92]. The gene discussed is APOE; the disease is Alzheimer disease.